4.39
price down icon1.79%   -0.08
after-market アフターアワーズ: 4.43 0.04 +0.91%
loading
前日終値:
$4.47
開ける:
$4.4
24時間の取引高:
3.06M
Relative Volume:
1.29
時価総額:
$476.62M
収益:
-
当期純損益:
$-223.12M
株価収益率:
-2.1846
EPS:
-2.0095
ネットキャッシュフロー:
$-190.49M
1週間 パフォーマンス:
-10.77%
1か月 パフォーマンス:
+17.38%
6か月 パフォーマンス:
+43.00%
1年 パフォーマンス:
-48.11%
1日の値動き範囲:
Value
$4.17
$4.48
1週間の範囲:
Value
$4.17
$5.1199
52週間の値動き範囲:
Value
$2.19
$8.80

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
名前
Rocket Pharmaceuticals Inc
Name
セクター
Healthcare (1114)
Name
電話
646-440-9100
Name
住所
350 FIFTH AVENUE, NEW YORK, NY
Name
職員
202
Name
Twitter
@rocketpharma
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
RCKT's Discussions on Twitter

Compare RCKT vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RCKT
Rocket Pharmaceuticals Inc
4.39 485.30M 0 -223.12M -190.49M -2.0095
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.05 114.72B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
737.45 78.67B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
684.50 42.38B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
311.10 41.75B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
282.72 31.33B 5.36B 287.73M 924.18M 2.5229

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-18 ダウングレード JP Morgan Neutral → Underweight
2025-08-20 アップグレード BofA Securities Neutral → Buy
2025-07-25 ダウングレード BofA Securities Buy → Neutral
2025-05-30 ダウングレード Evercore ISI Outperform → In-line
2025-05-28 ダウングレード Goldman Neutral → Sell
2025-05-28 ダウングレード JP Morgan Overweight → Neutral
2025-05-28 ダウングレード Jefferies Buy → Hold
2025-05-28 ダウングレード Leerink Partners Outperform → Market Perform
2025-05-28 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-05-27 ダウングレード Needham Buy → Hold
2025-05-27 ダウングレード TD Cowen Buy → Hold
2025-03-12 開始されました BMO Capital Markets Outperform
2024-12-30 開始されました Wedbush Outperform
2024-12-18 開始されました Jefferies Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-04-02 開始されました Goldman Neutral
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-02-01 開始されました Morgan Stanley Overweight
2022-11-08 開始されました Canaccord Genuity Buy
2022-11-01 開始されました BTIG Research Buy
2022-07-08 開始されました Raymond James Outperform
2021-10-20 再開されました Cowen Outperform
2021-03-02 開始されました Stifel Buy
2021-02-18 開始されました Needham Buy
2020-12-16 開始されました UBS Buy
2020-12-08 ダウングレード Oppenheimer Outperform → Perform
2020-07-02 開始されました JP Morgan Overweight
2020-06-25 再開されました BofA/Merrill Buy
2020-06-01 再開されました Oppenheimer Outperform
2019-11-06 開始されました Chardan Capital Markets Buy
2019-09-26 開始されました Piper Jaffray Overweight
2019-04-23 開始されました Robert W. Baird Outperform
2019-03-15 開始されました BofA/Merrill Buy
2019-02-05 開始されました Oppenheimer Outperform
2018-09-13 開始されました Ladenburg Thalmann Buy
2018-07-10 開始されました William Blair Outperform
すべてを表示

Rocket Pharmaceuticals Inc (RCKT) 最新ニュース

pulisher
Mar 18, 2026

Aug Drivers: Can Rocket Pharmaceuticals Inc expand into new markets2026 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 17, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.4%Here's What Happened - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Rocket Pharmaceuticals to present LAD I advances at primary immune deficiency workshop - Traders Union

Mar 17, 2026
pulisher
Mar 17, 2026

Morgan Stanley names Rocket Pharmaceuticals (RCKT) as key beneficiary of 2026 biotech sector recovery - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

RCKT's Q4 loss narrower than estimated, pipeline in focus - MSN

Mar 17, 2026
pulisher
Mar 14, 2026

Suvretta Capital Management LLC Cuts Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Rocket Pharmaceuticals, Inc. $RCKT Holdings Trimmed by Prosight Management LP - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Chart Watch: Is Rocket Pharmaceuticals Inc forming a bullish divergence2026 Levels & Fast Gain Swing Alerts - baoquankhu1.vn

Mar 14, 2026
pulisher
Mar 12, 2026

Rocket Pharmaceuticals Stock Drops Pre-Market After FDA Pauses Gene Therapy Trial Over Patient Death: Retail Turns Bullish - MSN

Mar 12, 2026
pulisher
Mar 12, 2026

Insider Buy: Is Rocket Pharmaceuticals Inc part of any ETF2026 Earnings & AI Enhanced Trading Alerts - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 11, 2026

Rocket Pharmaceuticals Enters New Sales Agreement with Cantor Fitzgerald, Terminates Prior Equity Offering Arrangement - Minichart

Mar 11, 2026
pulisher
Mar 11, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8%Should You Sell? - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Rocket Pharmaceuticals Launches New $100M At-The-Market Program - TipRanks

Mar 11, 2026
pulisher
Mar 11, 2026

[EFFECT] ROCKET PHARMACEUTICALS, INC. SEC Filing - Stock Titan

Mar 11, 2026
pulisher
Mar 10, 2026

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement - Investing.com

Mar 10, 2026
pulisher
Mar 10, 2026

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement By Investing.com - Investing.com South Africa

Mar 10, 2026
pulisher
Mar 10, 2026

Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri - GuruFocus

Mar 10, 2026
pulisher
Mar 10, 2026

Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

According to the latest filing with the U.S. Securities and Exchange Commission, biotechnology company Rocket Pharmaceuticals, Inc. has officially signed an equity sales agreement with renowned financial institution Cantor Fitzgerald & Co. - Bitget

Mar 10, 2026
pulisher
Mar 10, 2026

Rocket Pharmaceuticals (RCKT) launches $100M at-the-market stock offering with Cantor - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Form 424B5 ROCKET PHARMACEUTICALS, - StreetInsider

Mar 10, 2026
pulisher
Mar 10, 2026

Rocket Pharmaceuticals (RCKT) launches up to $100M ATM offering with Cantor - Stock Titan

Mar 10, 2026
pulisher
Mar 09, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4%What's Next? - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

UniQure leads genetic medicine biotech rally after news of Prasad’s exit - BioPharma Dive

Mar 09, 2026
pulisher
Mar 08, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen - MarketBeat

Mar 08, 2026
pulisher
Mar 06, 2026

Short Covering: Is Rocket Pharmaceuticals Inc Equity Warrant attractive for institutional investorsDollar Strength & Low Drawdown Investment Ideas - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Weekly Recap: Is Rocket Pharmaceuticals Inc showing insider buyingQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

RCKT SEC FilingsRocket Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 05, 2026
pulisher
Mar 04, 2026

RCKT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 04, 2026
pulisher
Mar 04, 2026

Canaccord Genuity Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT) - The Globe and Mail

Mar 04, 2026
pulisher
Mar 03, 2026

Rocket gene therapy among at least 7 PDUFA dates at FDA in March - BioCentury

Mar 03, 2026
pulisher
Mar 03, 2026

Wedbush sees Rocket Pharmaceuticals as significantly undervalued as cardiac gene therapy pipeline advances - Yahoo! Finance Canada

Mar 03, 2026
pulisher
Mar 02, 2026

Rocket Pharmaceuticals (NASDAQ: RCKT) files $400M shelf to raise capital - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Brokers Set Expectations for RCKT FY2026 Earnings - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Rocket Pharmaceuticals: Advancing Gene Therapy Pipeline and High-Confidence KRESLADI Approval Drive Buy Rating - TipRanks

Mar 02, 2026
pulisher
Mar 01, 2026

Chart Watch: Is Rocket Pharmaceuticals Inc showing insider buying2025 Market Outlook & Weekly Breakout Watchlists - baoquankhu1.vn

Mar 01, 2026
pulisher
Feb 28, 2026

Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

Cantor Fitzgerald Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT) - The Globe and Mail

Feb 28, 2026
pulisher
Feb 28, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded to "Hold" at Wall Street Zen - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus - The Globe and Mail

Feb 28, 2026
pulisher
Feb 28, 2026

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring A 71% Upside Potential - DirectorsTalk Interviews

Feb 28, 2026
pulisher
Feb 27, 2026

Rocket Pharmaceuticals Q4 2025 Financial Report & Annual ResultsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Feb 27, 2026
pulisher
Feb 27, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 14.3% Following Earnings Beat - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Cantor Fitzgerald Raises Rocket Pharmaceuticals (RCKT) Price Tar - GuruFocus

Feb 27, 2026
pulisher
Feb 27, 2026

Cantor Fitzgerald Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of "Hold" from Analysts - MarketBeat

Feb 27, 2026
pulisher
Feb 26, 2026

Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Rocket Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Rocket Pharmaceuticals: Q4 Earnings Snapshot - theheraldreview.com

Feb 26, 2026

Rocket Pharmaceuticals Inc (RCKT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
大文字化:     |  ボリューム (24 時間):